Leo Pharma Inc. Is Withdrawing The Drug Picato (ingenol Mebutate), Used To Treat Skin Lesions, Due To The Potential Increased Risk Of Skin Cancer

Summary LEO Pharma Inc. is recalling Picato (Ingenol mebutate), a medication used to treat certain skin lesions, because it may increase the risk of skin cancer. The recall affects Picato products distributed across Canada.

Category

consumer product recall

Country

Canada

Agency

HC-PRODUCTS

Recall date

2020-10-27

Status

Ongoing

Distribution

Canada-wide

Official recall notice from HC-PRODUCTS

Recall details on Nibble Recalls: https://trynibble.app/recalls/97aad937-6b90-47c6-8d36-4bb9eb76b7d4